Literature DB >> 1850036

Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis.

T M Horton1, T S Ranheim, L Aquino, D I Kusher, S K Saha, C F Ware, W S Wold, L R Gooding.   

Abstract

A 14,700-kDa protein (14.7K) encoded by the E3 region of adenovirus has been shown to protect adenovirus-infected mouse C3HA cells from lysis by tumor necrosis factor (TNF) (L. R. Gooding, L. W. Elmore, A. E. Tollefson, H. A. Brady, and W. S. M. Wold, Cell 53:341-346, 1988). These infected cells are sensitized to TNF by expression of the adenovirus E1A proteins (P. Duerksen-Hughes, W. S. M. Wold, and L. R. Gooding, J. Immunol. 143:4193-4200, 1989). In this study we show that 14.7K suppresses TNF cytolysis independently of adenovirus infection. Mouse C3HA and C127 cells were transfected with the 14.7K gene controlled by the mouse metallothionein promoter, and permanent 14.7K-expressing cell lines were tested for sensitivity to TNF cytolysis. Transfected cells which were sensitized to TNF either by inhibitors of protein synthesis, microfilament-destabilizing agents, or adenovirus infection were found to be resistant to TNF cytolysis. Two monoclonal antibodies were isolated and used to quantitate 14.7K in transfected and infected cells. Enzyme-linked immunosorbent assay (ELISA) analysis with these monoclonal antibodies and 14.7K immunoblots showed that 14.7K expression can be induced with cadmium in C3HA and C127 transfectants. The 14.7K induction correlated with a dose-dependent decrease in sensitivity to TNF cytotoxicity. The 14.7K protein does not substantially alter cell surface TNF receptor numbers or affinity on C3HA mouse fibroblasts, as determined by Scatchard analysis of 125I-TNF binding. The 14.7K protein also does not alter TNF signal transduction in general, because TNF induction of cell surface class I major histocompatibility complex molecules on 14.7K transfectants was unmodified. Our findings indicate that the adenovirus 14.7K protein functions as a specific inhibitor of TNF cytolysis in the absence of other adenovirus proteins and thus is a unique tool to study the mechanism of TNF cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1850036      PMCID: PMC240621     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  81 in total

1.  Tumor necrosis factor selectively inhibits activation of human B cells by Epstein-Barr virus.

Authors:  O Janssen; D Kabelitz
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

2.  Expression of tumor necrosis factor receptors on human monocytes and internalization of receptor bound ligand.

Authors:  K Imamura; D Spriggs; D Kufe
Journal:  J Immunol       Date:  1987-11-01       Impact factor: 5.422

3.  Cytostatic and cytotoxic activity of tumor necrosis factor on human cancer cells.

Authors:  V Ruggiero; K Latham; C Baglioni
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

4.  The molecular basis of a familial apoE deficiency. An acceptor splice site mutation in the third intron of the deficient apoE gene.

Authors:  C Cladaras; M Hadzopoulou-Cladaras; B K Felber; G Pavlakis; V I Zannis
Journal:  J Biol Chem       Date:  1987-02-15       Impact factor: 5.157

5.  Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses.

Authors:  P Scheurich; B Thoma; U Ucer; K Pfizenmaier
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

6.  Antiviral effects of recombinant tumour necrosis factor in vitro.

Authors:  J Mestan; W Digel; S Mittnacht; H Hillen; D Blohm; A Möller; H Jacobsen; H Kirchner
Journal:  Nature       Date:  1986 Oct 30-Nov 5       Impact factor: 49.962

7.  Continuous internalization of tumor necrosis factor receptors in a human myosarcoma cell line.

Authors:  N Watanabe; H Kuriyama; H Sone; H Neda; N Yamauchi; M Maeda; Y Niitsu
Journal:  J Biol Chem       Date:  1988-07-25       Impact factor: 5.157

8.  Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells.

Authors:  M Tsujimoto; Y K Yip; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

9.  Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells.

Authors:  B A Beutler; A Cerami
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

10.  Adenovirus E1A-mediated regulation of class I MHC expression.

Authors:  R T Vaessen; A Houweling; A Israel; P Kourilsky; A J van der Eb
Journal:  EMBO J       Date:  1986-02       Impact factor: 11.598

View more
  30 in total

1.  An adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis complexes with dynein and a small GTPase.

Authors:  S A Lukashok; L Tarassishin; Y Li; M S Horwitz
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 2.  Mechanisms of immune escape in viral hepatitis.

Authors:  W Rosenberg
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

3.  Characterization of Ad5 E3-14.7K, an adenoviral inhibitor of apoptosis: structure, oligomeric state, and metal binding.

Authors:  Hee-Jung Kim; Mark P Foster
Journal:  Protein Sci       Date:  2002-05       Impact factor: 6.725

4.  Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B.

Authors:  Brian P McSharry; Hans-Gerhard Burgert; Douglas P Owen; Richard J Stanton; Virginie Prod'homme; Martina Sester; Katja Koebernick; Veronika Groh; Thomas Spies; Steven Cox; Ann-Margaret Little; Eddie C Y Wang; Peter Tomasec; Gavin W G Wilkinson
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

5.  Homologous recombination in E3 genes of human adenovirus species D.

Authors:  Gurdeep Singh; Christopher M Robinson; Shoaleh Dehghan; Morris S Jones; David W Dyer; Donald Seto; James Chodosh
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

6.  The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis.

Authors:  J Shisler; C Yang; B Walter; C F Ware; L R Gooding
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains.

Authors:  Y Li; J Kang; M S Horwitz
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

8.  The adenovirus death protein (E3-11.6K) is required at very late stages of infection for efficient cell lysis and release of adenovirus from infected cells.

Authors:  A E Tollefson; A Scaria; T W Hermiston; J S Ryerse; L J Wold; W S Wold
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  The role of mouse adenovirus type 1 early region 1A in acute and persistent infections in mice.

Authors:  K Smith; C C Brown; K R Spindler
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Adenovirus E3 14.7-kilodalton protein, an antagonist of tumor necrosis factor cytolysis, increases the virulence of vaccinia virus in severe combined immunodeficient mice.

Authors:  J M Tufariello; S Cho; M S Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.